Cooperative Agreement 72066020CA00003
Award Date
9/30/20
Completion Date
9/29/25
Dollars Obligated
$38M
Federal Agency
US Mission in Democratic Republic of Congo
Awardee
Sanru (GQKJZ85MH5K4)
Federal Grant Program
98.001
Assistance Type
Cooperative Agreement
Place of Performance
Kinshasa, Democratic Republic of the Congo
Similar Awards
This is a fixed-amount Cooperative Agreement awarded by the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program. The award provides an estimated $15.3M in funding over 5 years to Sanru, a non-profit organization based in the Democratic Republic of the Congo (DRC), to deliver comprehensive healthcare services in Kinshasa. The funding will be provided in two phases - $8.7M for Phase I and $6.6M for Phase II - to support Sanru's...
This $31,253,928 Cooperative Agreement award from the U.S. Agency for International Development (USAID), under the Foreign Assistance for Programs Overseas (CFDA 98.001) program, supports tuberculosis (TB) control and prevention activities in Kenya. The 5-year project, which commenced on May 28, 2024, aims to assist the Kenyan Ministry of Health in its efforts to control and prevent the spread of TB in the country. The primary recipient, Centre For Health Solutions - Kenya, a non-profit...
This is a $11,097,080 Cooperative Agreement awarded by the U.S. Centers for Disease Control and Prevention (CDC) under the Global AIDS program (CFDA 93.067) of the President's Emergency Plan for AIDS Relief (PEPFAR). The grant will be implemented by Global Health Systems Solutions (GHSS) in the Democratic Republic of the Congo (DRC) to build laboratory capacity and improve the quality of HIV testing services and timely release of results for HIV prevention, treatment and care. Key objectives...
The U.S. Agency for International Development (USAID) awarded a $287,878,180 Cooperative Agreement (CFDA 98.001 - USAID Foreign Assistance for Programs Overseas) to Family Health International (FHI 360) to scale up and improve management of drug-resistant tuberculosis (DR-TB) in USAID-supported countries. The award period is from October 1, 2024 to September 30, 2029. The key products and services to be delivered under this global award include: Expanding access to high-quality DR-TB treatment...
This Cooperative Agreement award for $4,650,276.00 from the U.S. Agency for International Development (USAID) under the Foreign Assistance for Programs Overseas (CFDA 98.001) program supports the "CURE TUBERCULOSIS PROJECT 2" initiative in Kyrgyzstan. The primary awardee, JSI Research & Training Institute Inc., a non-profit organization based in Boston, will provide comprehensive technical assistance, research, and program implementation services to address tuberculosis (TB) in the...
The U.S. Agency for International Development (USAID) awarded a $4,003,313 Cooperative Agreement under the Foreign Assistance Program (CFDA 98.001) to the Khmer HIV/AIDS NGO Alliance (Khana), a non-profit organization based in Phnom Penh, Cambodia. The purpose of this 5-year award, running from October 2024 to September 2029, is to increase access to and sustainability of quality tuberculosis (TB) diagnosis, treatment, and prevention services in Cambodia. The key objectives of this project are...
The Centers for Disease Control and Prevention (CDC) awarded a $550,000 five-year Cooperative Agreement under the Global Tuberculosis: Developing, Evaluating, Implementing Evidence-based and Innovative Approaches to Find, Cure, and Prevent Tuberculosis Globally (CFDA 93.494) program to the Union Internationale Contre la Tuberculose et les Maladies Respiratoires (Uitmr), an international non-profit organization focused on global tuberculosis (TB) and respiratory disease prevention and...
The federal Cooperative Agreement award with ID NU2GGH002528 was issued by the Centers for Disease Control and Prevention (CDC) under the Global AIDS federal grant program (CFDA 93.067), which is part of the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) initiative. The $6,749,031 award was granted to the Association de Sante Familiale (ASF), a local non-profit organization, and PATH, a U.S.-based international NGO, to implement the USHINDI (meaning "Victory") project in...
This Project Grant award from the National Institutes of Health's John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to develop and assess the feasibility of a diagnostic tool for post-tuberculosis (TB) lung disease that can be deployed in Ugandan primary healthcare settings with limited access to specialized diagnostics. The $108,237 award to Mbarara University of Science and Technology (MUST) in Uganda will fund three main activities: (1)...
This $109,704 Project Grant award from the John E. Fogarty International Center (CFDA 93.989 - International Research and Research Training) aims to develop and pilot an implementation strategy for integrating tuberculosis (TB) treatment into community pharmacies in Uganda to improve TB/HIV outcomes. The key products and services to be delivered under this 5-year award to the Infectious Diseases Institute LIMITED (IDI) in Kampala, Uganda include: Exploring barriers and facilitators to...